Refine
Has Fulltext
- yes (22)
Is part of the Bibliography
- yes (22)
Year of publication
Document Type
- Journal article (22)
Language
- English (22)
Keywords
- Merkel cell carcinoma (8)
- polyomavirus (4)
- cell staining (3)
- melanoma (3)
- Merkel cell polyomavirus (2)
- PD-L1 (2)
- apoptosis (2)
- large T antigen (2)
- melanomas (2)
- polymavirus (2)
- B cell (1)
- B-cell lymphoma (1)
- B-cells (1)
- BRAF (1)
- CD274 (1)
- CD30 (1)
- CD8(+) (1)
- Cutaneous lymphoma (1)
- EGR1 (1)
- Epigenetic regulation (1)
- GSK3 (1)
- HDAC (1)
- Hautkrebs (1)
- Histone deacetylase (1)
- JAK2 (1)
- Krebs <Medizin> (1)
- LSD1 (1)
- Large T antigen (1)
- Lysine-specific methylase (1)
- MCC (1)
- MCPyV (1)
- MCV-negative (1)
- Medizin (1)
- Melanoma (1)
- Merkel cell carcinoma (MCC) (1)
- PIK3CA mutations (1)
- RNA modification (1)
- T antigen (1)
- T-antigen (1)
- T-antigens (1)
- TP53 (1)
- Tubulin (1)
- YTHDF1 (1)
- akt (1)
- antibody–drug conjugates (1)
- antitumor immunity (1)
- artesunate (1)
- breast cancer (1)
- cancer (1)
- cancer treatment (1)
- case report (1)
- cell cycle (1)
- cell membranes (1)
- chromatin regulator (1)
- copy number variations (1)
- coronavirus disease 2019 (1)
- cultured fibroplasts (1)
- cutaneous T-cell lymphoma and Merkel cell carcinoma (1)
- cutaneous T-cell-lymphoma (1)
- epigenetic reader (1)
- epithelial (1)
- epitranscriptome (1)
- expression (1)
- ferroptosis (1)
- fibroblast (1)
- glycogen synthase kinase 3 (1)
- heat shock response (1)
- histogenesis (1)
- histology (1)
- histone (1)
- histone methyltransferase PRDM8 (1)
- immune cell infiltration (1)
- immunohistochemistry techniques (1)
- large cell transformation (1)
- lung cancer (1)
- lymphocytes (1)
- m\(^6\)A (1)
- melanin (1)
- melanocytes (1)
- melanoma cell (1)
- melanoma cells (1)
- membrane proteins (1)
- membrans proteins (1)
- merkel cell polyomavirus (MCPyV) (1)
- miRNA (1)
- microvessel density (1)
- migraine (1)
- mycosis fungoides (1)
- oncodermatology (1)
- origin (1)
- p53 (1)
- panel sequencing (1)
- phthalazinone pyrazole (1)
- polymerase chain reaction (1)
- rare (1)
- reporter genes (1)
- responses (1)
- retinoblastoma protein (1)
- senescence (1)
- severe acute respiratory syndrome coronavirus 2 (1)
- skin squamous cell carcinoma (1)
- squamous cell (1)
- subtypes (1)
- survival (1)
- tertiary lymphoid structures (1)
- triptan (1)
- tumor (1)
- tumor suppressor genes (1)
- tumors (1)
- vascular endothelial growth (1)
- vesicles (1)
- viral carcinogenesis (1)
Institute
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (22) (remove)
Merkel cell carcinoma (MCC) is a highly aggressive skin cancer with an increasing incidence. The understanding of the molecular carcinogenesis of MCC is limited. Here, we scrutinized the PI3K/AKT pathway, one of the major pathways activated in human cancer, in MCC. Immunohistochemical analysis of 41 tumor tissues and 9 MCC cell lines revealed high levels of AKT phosphorylation at threonine 308 in 88% of samples. Notably, the AKT phosphorylation was not correlated with the presence or absence of the Merkel cell polyoma virus (MCV). Accordingly, knock-down of the large and small T antigen by shRNA in MCV positive MCC cells did not affect phosphorylation of AKT. We also analyzed 46 MCC samples for activating PIK3CA and AKT1 mutations. Oncogenic PIK3CA mutations were found in 2/46 (4%) MCCs whereas mutations in exon 4 of AKT1 were absent. MCC cell lines demonstrated a high sensitivity towards the PI3K inhibitor LY-294002. This finding together with our observation that the PI3K/AKT pathway is activated in the majority of human MCCs identifies PI3K/AKT as a potential new therapeutic target for MCC patients.
Merkel cell carcinoma (MCC) is frequently caused by the Merkel cell polyomavirus (MCPyV), and MCPyV-positive tumor cells depend on expression of the virus-encoded T antigens (TA). Here, we identify 4-[(5-methyl-1H-pyrazol-3-yl)amino]-2H-phenyl-1-phthalazinone (PHT) — a reported inhibitor of Aurora kinase A — as a compound inhibiting growth of MCC cells by repressing noncoding control region (NCCR)-controlled TA transcription. Surprisingly, we find that TA repression is not caused by inhibition of Aurora kinase A. However, we demonstrate that β-catenin — a transcription factor repressed by active glycogen synthase kinase 3 (GSK3) — is activated by PHT, suggesting that PHT bears a hitherto unreported inhibitory activity against GSK3, a kinase known to function in promoting TA transcription. Indeed, applying an in vitro kinase assay, we demonstrate that PHT directly targets GSK3. Finally, we demonstrate that PHT exhibits in vivo antitumor activity in an MCC xenograft mouse model, suggesting a potential use in future therapeutic settings for MCC.